Intellia Therapeutics, Inc. (NTLA)
11.64
-0.36
(-3.04%)
USD |
NASDAQ |
Feb 12, 16:00
11.65
+0.02
(+0.13%)
After-Hours: 20:00
Intellia Therapeutics Profit Margin (Quarterly) : -735.2% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -1.16K% |
| Regeneron Pharmaceuticals, Inc. | 21.74% |
| Pacific Biosciences of California, Inc. | -98.85% |
| Personalis, Inc. | -149.4% |
| Twist Bioscience Corp. | -29.42% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -54.66% |
| Return on Assets | -43.08% |
| Return on Invested Capital | -47.33% |
| Gross Profit Margin (Quarterly) | 64.19% |
| Operating Margin (Quarterly) | -808.9% |
| Return on Net Operating Assets | -242.3% |